141 related articles for article (PubMed ID: 35265169)
21. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
23. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
Zhou H; Sun Z; Li S; Wang X; Zhou X
Cancer Gene Ther; 2018 Feb; 25(1-2):39-46. PubMed ID: 29234152
[TBL] [Abstract][Full Text] [Related]
25. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
26. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer.
Javed Z; Ahmed Shah F; Rajabi S; Raza Q; Iqbal Z; Ullah M; Ahmad T; Salehi B; Sharifi-Rad M; Pezzani R; Yaqoob F; Sadia H; Iriti M; Sharifi-Rad J; Cho WC
Asian Pac J Cancer Prev; 2020 Feb; 21(2):281-287. PubMed ID: 32102500
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of long noncoding RNA SNHG7 inhibits the proliferation and promotes apoptosis of thyroid cancer cells by downregulating BDNF.
Wang YH; Huo BL; Li C; Ma G; Cao W
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4815-4821. PubMed ID: 31210313
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.
Li HM; Yang H; Wen DY; Luo YH; Liang CY; Pan DH; Ma W; Chen G; He Y; Chen JQ
Horm Metab Res; 2017 May; 49(5):388-399. PubMed ID: 28351094
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.
Yang S; Wang J; Ge W; Jiang Y
J Cell Biochem; 2018 Aug; 119(8):6953-6960. PubMed ID: 29737563
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
[TBL] [Abstract][Full Text] [Related]
31. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis.
Zheng L; Li S; Zheng X; Guo R; Qu W
Int Immunopharmacol; 2021 Jan; 90():107185. PubMed ID: 33218938
[TBL] [Abstract][Full Text] [Related]
32. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer.
Xu K; Feng Y
J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670
[TBL] [Abstract][Full Text] [Related]
33. Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer.
Ding J; Wang F; Xiang T; Qiao M
Oncol Res; 2018 Aug; 26(7):1047-1053. PubMed ID: 29321094
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer.
Kim D; Lee WK; Jeong S; Seol MY; Kim H; Kim KS; Lee EJ; Lee J; Jo YS
Mol Cell Endocrinol; 2016 Aug; 431():36-45. PubMed ID: 27151833
[TBL] [Abstract][Full Text] [Related]
35. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
36. The diagnostic and prognostic significance of long noncoding RNAs expression in thyroid cancer: A systematic review and meta-analysis.
Jing W; Li X; Peng R; Lv S; Zhang Y; Cao Z; Tu J; Ming L
Pathol Res Pract; 2018 Mar; 214(3):327-334. PubMed ID: 29487006
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
[TBL] [Abstract][Full Text] [Related]
38. Identification of Long Noncoding RNA MIR22HG as a Novel Biomarker in Thyroid Cancer.
Qin L; Luo JZ; Tang XL; Han CG
Pathol Oncol Res; 2019 Apr; 25(2):703-710. PubMed ID: 30539522
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
[TBL] [Abstract][Full Text] [Related]
40. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
